COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,959 Articles (22,604 medRxiv, 8,355 bioRxiv)

Most recent first Previous |  Page 3062: Articles 30611-30620  | Next

An epidemiological forecast model and software assessing interventions on COVID-19 epidemic in China
Song, P. X., Wang, L., Zhou, Y., He, J., Zhu, B., Wang, F., Tang, L., Eisenberg, M.
10.1101/2020.02.29.20029421 — Posted: 2020-03-03
Highly ACE2 Expression in Pancreas May Cause Pancreas Damage After SARS-CoV-2 Infection
Liu, F., Long, X., Zou, W., Fang, M., Wu, W., Li, W., Zhang, B., Zhang, W., Chen, X., Zhang, Z.
10.1101/2020.02.28.20029181 — Posted: 2020-03-03
A simple model to assess Wuhan lock-down effect and region efforts during COVID-19 epidemic in China Mainland
zheming, Y., Yuan, C.
10.1101/2020.02.29.20029561 — Posted: 2020-03-03
The spatiotemporal estimation of the dynamic risk and the international transmission of 2019 Novel Coronavirus (COVID-19) outbreak: A global perspective
Lin, Y.-C., Chi, W.-J., Lin, Y.-T., Lai, C.-Y.
10.1101/2020.02.29.20029413 — Posted: 2020-03-03
Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control
Li, Z., Ge, J., Yang, M., Feng, J., Qiao, M., Jiang, R., Bi, J., Zhan, G., Xu, X., Wang, L., Zhou, Q., Zhou, C., Pan, Y., Liu, S., Zhang, H., Yang, J., Zhu, B., Hu, Y., Hashimoto, K., Jia, Y., Wang, H., Wang, R., Liu, C., Yang, C.
10.1101/2020.02.29.20029322 — Posted: 2020-03-03
Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient
Harcourt, J., Tamin, A., Lu, X., Kamili, S., Kumar Sakthivel, S., Wang, L., Murray, J., Queen, K., Lynch, B., Whitaker, B., Tao, Y., Paden, C., Zhang, J., Li, Y., Uehara, A., Wang, H., Goldsmith, C., Bullock, H., Gautam, R., Schindewolf, C., Lokugamage, K. G., Scharton, D., Plante, J., Mirchandani, D., Widen, S., Narayanan, K., Makino, S., Ksiazek, T., Plante, K. S., Weaver, S., Menachery, V. D., Thornburg, N. J.
10.1101/2020.03.02.972935 — Posted: 2020-03-03 Discussion: Onsite
Evidence for RNA editing in the transcriptome of 2019 Novel Coronavirus
Di Giorgio, S., Martignano, F., Torcia, M. G., Mattiuz, G., Conticello, S. G.
10.1101/2020.03.02.973255 — Posted: 2020-03-03 Discussion: Onsite
Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2
Kim, Y., Jedrzejczak, R., Maltseva, N. I., Endres, M., Godzik, A., Michalska, K., Joachimiak, A.
10.1101/2020.03.02.968388 — Posted: 2020-03-03
Multi-epitope vaccine design using an immunoinformatics approach for 2019 novel coronavirus in China (SARS-CoV-2)
Feng, Y., Qiu, M., Zou, S., Li, Y., Luo, K., Chen, R., Sun, Y., Wang, K., Zhuang, X., Zhang, S., Chen, S., Mo, F.
10.1101/2020.03.03.962332 — Posted: 2020-03-03 Discussion: Onsite
Estimation of local novel coronavirus (COVID-19) cases in Wuhan, China from off-site reported cases and population flow data from different sources
Zhuang, Z., Cao, P., Zhao, S., Lou, Y., Wang, W., Yang, S., Yang, L., He, D.
10.1101/2020.03.02.20030080 — Posted: 2020-03-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).